HemoScreen即时血液分析仪与三种常规分析仪在血细胞异常患者中的比较
本研究纳入137例血液病患者和健康供者,比较HemoScreen即时血液分析仪与Sysmex XN、Beckman Coulter DxH 560及HORIBA Yumizen H550在异常样本中的CBC和WBC分类参数。HemoScreen静脉与毛细血管血测量无显著线性偏离(Cusum p=0.14–0.98),ANC和PLT虽差异有统计学意义但中位差异小且无临床意义;与常规分析仪分析一致性良好,PLT和HGB部分比较差异显著但相对偏差多在外部质量评估限内,PLT≤50×10^9/L亚组变异性较大。结论认为HemoScreen可作为常规血液学监测的可靠补充POCT工具。
要点
- HemoScreen静脉与毛细血管血测量无显著线性偏离,ANC和PLT差异虽显著但中位差异小且无临床意义。
- HemoScreen与三种常规分析仪分析一致性良好,PLT和HGB部分比较差异显著但相对偏差多在外部质量评估限内。
- PLT≤50×10^9/L亚组变异性较大,提示低血小板时需谨慎解读。
核心结论
- HemoScreen与所有评估的血液分析仪分析一致性良好,可能作为常规血液学监测的可靠补充POCT工具,包括血细胞异常患者。
研究设计与样本
- 研究纳入137例血液病患者和健康供者,采集静脉血和毛细血管血,评估WBC、ANC、HGB和PLT。
- 统计方法包括Passing–Bablok回归分析、Cusum检验、Wilcoxon符号秩检验和Hodges–Lehmann中位差异分析。
主要发现
- HemoScreen静脉与毛细血管血测量各评估参数Cusum检验无显著线性偏离(p=0.14–0.98)。
- ANC(p=0.0201)和PLT(p=0.0026)差异有统计学意义,但中位差异小且无临床意义。
- HemoScreen与常规分析仪静脉血比较分析一致性良好,无显著线性偏离。
- PLT和HGB部分比较差异有统计学意义,但多数比较相对偏差在外部质量评估限内。
- PLT≤50×10^9/L亚组变异性较大。
临床怎么用
- HemoScreen可用于常规血液学监测的补充POCT工具,包括血细胞异常患者。
- 低血小板(≤50×10^9/L)样本结果变异性较大,解读时需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ABSTRACT Introduction HemoScreen is a portable point-of-care testing (POCT) haematology analyser capable of measuring 20 complete blood count (CBC) parameters, including a 5-part leukocyte differential, from venous and capillary blood. This study compared selected CBC and white blood cell (WBC) differential parameters obtained using HemoScreen with those from three conventional haematology analysers: Sysmex XN, Beckman Coulter DxH 560, and HORIBA Yumizen H550 in abnormal samples. Methods Venous and capillary blood was collected from 137 patients with haematological disorders and healthy donors. We evaluated WBC, absolute neutrophil count (ANC), haemoglobin (HGB), and platelets (PLT). Statistical analysis included Passing–Bablok regression analysis, Cusum test, Wilcoxon signed-rank test, and Hodges–Lehmann median difference analysis. Results Comparison of venous and capillary blood measurements using HemoScreen demonstrated no significant deviation from linearity for any evaluated parameter according to the Cusum test (p = 0.14–0.98). Although statistically significant differences were observed for ANC (p = 0.0201) and PLT (p = 0.0026), the median differences remained small and clinically irrelevant. Comparison of venous blood measurements between HemoScreen and conventional analysers demonstrated strong analytical agreement without significant deviation from linearity. Statistically significant differences were observed in several comparisons, particularly for PLT and HGB measurements; however, the approximate relative bias remained within external quality assessment limits in most comparisons, with greater variability for PLT in the ≤ 50 × 109/L subgroup. Conclusions HemoScreen demonstrated good analytical agreement with all evaluated haematology analysers and may represent a reliable complementary POCT tool for routine haematological monitoring, including patients with abnormal blood counts.
引用
- International Journal of Laboratory Hematology:Comparison of the HemoScreen Point‐Of‐Care Haematology Analyser With Sysmex XN, Beckman Coulter DxH 560 and HORIBA Yumizen H550 in Patients With Abnormal Blood Counts
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。